Drug Target Review’s Cell & Gene Therapy Advancements Online Summit
Date: 3 November 2021 - 4 November 2021
Time: 2:00 pm - 10:00 pm
Website: bit.ly/3jE1W0S
Why attend?
As advancements in cell and gene therapies continue to accelerate and reach the clinic, the spotlight is now focused on improving safety, efficacy and scale-up at the pre-clinical stage.
Drug Target Review’s new virtual summit will explore the latest developments in cell and gene therapies. In this two-day online conference, gain access to the latest research from leading scientists and experts.
Speakers from global pharmaceutical companies, biotech organizations, CROs and academic institutes will present the latest innovations in the application of cell and gene therapies across a range of indications and how researchers can work towards delivering innovative treatments to patients.
Sessions include:
- CRISPR – where we are and what’s next
- Combatting the immune response to AAV vectors
- Utilising CAR T-cell therapies against solid tumours
- Regenerative medicine – stem cell therapies
- Plus much more!
Please note that the free pass is limited to active researchers from pharmaceutical companies, biotech organisations, research centres, academic institutes and CROs.
Related topics
Biologics, Biopharmaceuticals, Gene Therapy, Genome Editing, Immuno-oncology, Immunotherapy, Molecular Targets, Oncology
